KRAS and familial pancreatic carcinoma: Zhang Y. et al. [18] reported that IL-17 recruited neutrophils, triggered the production of NETs, and excluded cytotoxic CD8+ T cells from tumors in a KRAS-induced pancreatic cancer model.